文献速递骨质疏松与代谢性骨病

每周达成推荐步数频率与绝经前后女性定量超声指标下降的关联:东北医疗megabank社区队列4年前瞻研究

Association between the frequency of achieving recommended daily step counts and a decline in quantitative ultrasound measurements in premenopausal and postmenopausal women: a 4-year prospective study of the Tohoku Medical Megabank Community-Based Cohort study.
PubMed 文献 · Osteoporos Int · 2026-10-23

该前瞻性队列研究纳入3529名女性(绝经前1013名,绝经后2516名),平均随访42.5个月,探讨每周达成7000步/天的天数与定量超声(QUS)测量值下降的关联。结果显示,绝经前女性每周≥3天达成7000步/天与QUS下降风险显著降低相关(RR 0.478,95%CI 0.271-0.843),而绝经后女性无显著关联(RR 0.937,95%CI 0.807-1.088)。每周1-2天达成在两组均无显著关联。

要点

  • 绝经前女性每周≥3天达成7000步/天与QUS下降风险降低相关。
  • 绝经后女性中,每周≥3天达成7000步/天与QUS下降无显著关联。
  • 每周仅1-2天达成7000步/天在绝经前后女性中均无显著关联。

核心结论

  • 在绝经前女性中,每周至少3天达成7000步/天与QUS测量值下降风险显著降低相关。
  • 在绝经后女性中,每周至少3天达成7000步/天与QUS测量值下降无显著关联,单纯步行可能不足以作为绝经后女性的有效策略。

研究设计与样本

  • 本研究为东北医疗megabank社区队列的前瞻性研究,基线调查于2013-2016年进行,随访调查于2017-2021年进行,平均随访42.5个月。
  • 共纳入3529名女性,其中绝经前1013名,绝经后2516名;每日步数通过计步器客观测量。

主要发现

  • 随访期间,绝经前女性发生结局70例,绝经后女性发生结局662例。
  • 在绝经前女性中,活跃组(每周≥3天达成7000步/天)相比不活跃组(0天)的结局风险显著降低(RR 0.478,95%CI 0.271-0.843)。
  • 在绝经后女性中,活跃组相比不活跃组的结局风险无统计学显著差异(RR 0.937,95%CI 0.807-1.088)。
  • 低活跃组(每周1-2天达成7000步/天)在绝经前和绝经后女性中均无显著关联。

关键数值与推荐

  • 推荐每日步数阈值为7000步/天,达成频率分为不活跃(0天/周)、低活跃(1-2天/周)和活跃(≥3天/周)。
  • 结局定义为QUS T值≤-2.5或自我报告的骨质疏松诊断。

临床怎么用

  • 对于绝经前女性,鼓励每周至少3天达成7000步/天可能有助于降低QUS测量值下降的风险。
  • 对于绝经后女性,仅靠步行可能不足以降低QUS测量值下降的风险,需考虑其他干预策略。

局限性

  • 本研究为观察性研究,无法确定因果关系。
  • 结局包含自我报告的骨质疏松诊断,可能存在信息偏倚。
  • 步数测量仅基于计步器,未考虑其他身体活动形式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Achieving 7000 steps/day on ≥3 days/week significantly reduced the risk of decline in quantitative ultrasound measurements in premenopausal women, but not in postmenopausal women. Less frequent achievement (1-2 days/week) showed no significant association in either group. PURPOSE: To examine the association between the frequency of achieving the recommended daily step count (7000 steps/day) and the incidence of a decline in quantitative ultrasound (QUS) measurements among pre- and postmenopausal women. METHODS: In this prospective cohort study of the Tohoku Medical Megabank Community-Based Cohort, baseline and follow-up surveys were conducted between 2013-2016 and 2017-2021 (mean follow-up: 42.5 months). Participants were 3529 women (1013 premenopausal, 2516 postmenopausal). Daily steps were objectively measured using pedometers. The number of days per week achieving 7000 steps was categorized as Inactive (0 days), Low active (1-2 days), and Active (≥3 days). The outcome was the incidence of a decline in QUS measurements, defined as a QUS T-score ≤-2.5 or a self-reported diagnosis of osteoporosis. Adjusted risk ratio (RR) and 95% confidence interval (CI) were calculated using modified Poisson regression models, with the Inactive group as the reference. RESULTS: During follow-up, the outcome occurred in 70 premenopausal and 662 postmenopausal women. In premenopausal women, the Active group had a significantly lower risk of the outcome compared to the Inactive group (RR: 0.478, 95% CI: 0.271 to 0.843). In postmenopausal women, no statistically significant association was observed (RR for the Active group: 0.937, 95% CI: 0.807 to 1.088). CONCLUSION: The findings suggest that the association appeared to differ by menopausal status, achieving 7000 steps/day on ≥3 days/week was associated with a significantly reduced risk of a decline in QUS measurements in premenopausal women. However, for postmenopausal women, walking alone may be an insufficient strategy.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Sato K, Chiba I, Nakaya N, et al. Association between the frequency of achieving recommended daily step counts and a decline in quantitative ultrasound measurements in premenopausal and postmenopausal women: a 4-year prospective study of the Tohoku Medical Megabank Community-Based Cohort study. Osteoporos Int. 2026. PMID: 42909484. doi:10.1007/s00198-026-08263-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。